Literature DB >> 8342236

Strategies to recruit plateletpheresis donors from a registry of HLA-typed, unrelated, bone marrow donors.

D C Bolgiano1, S Smith, S J Slichter.   

Abstract

Rising demand for single-donor platelet components--from random donors, to maintain platelet inventories, or from HLA-compatible donors, to support alloimmune platelet-refractory patients--necessitated increasing the size of a community plateletpheresis donor registry. This study compares two strategies for recruiting whole-blood donors into a plateletpheresis program. The whole-blood donors who were asked to participate in this study had recently joined an unrelated bone marrow donor registry and had been HLA-typed as part of that process. An in-person recruitment strategy, which was time-intensive for the apheresis donor coordinator, served as the standard. A by-mail strategy involved the mailing of recruitment materials to marrow-donor registry participants. Marrow-donor registry participants were approached about apheresis participation after they had indicated an interest in the plateletpheresis program by returning a tear-off section of an informational brochure that was sent to them along with their marrow-donor registry materials. A total of 852 marrow-donor registry participants were randomly assigned to one of two recruitment strategies, and the recruitment rates were the same (46%) for both methods. In addition, levels of apheresis participation and attrition rates of donors recruited by either strategy were comparable. Thus, the simple strategy of mailing information about a plateletpheresis program is a very cost-effective method of recruiting donors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8342236     DOI: 10.1046/j.1537-2995.1993.33893342751.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  1 in total

1.  How to motivate whole blood donors to become plasma donors.

Authors:  Gaston Godin; Marc Germain
Journal:  J Blood Transfus       Date:  2014-10-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.